Turn Biotechnologies Announces Landmark Study to Assess Effectiveness of ERA™ Therapy in Restoring Bone Marrow
- Written by PR Newswire
 |
Researchers from Children's Hospital of Philadelphia (CHOP) seek to expand treatment access for patients
MOUNTAIN VIEW, Calif., Dec. 3, 2024 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation and restoration company developing novel mRNA medicines for untreatable, age-related conditions, announced its latest study to assess the efficacy of...
